Genomic and epidemiological monitoring of yellow fever virus transmission potential

Carregando...
Imagem de Miniatura
Citações na Scopus
207
Tipo de produção
article
Data de publicação
2018
Editora
AMER ASSOC ADVANCEMENT SCIENCE
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
FARIA, N. R.
KRAEMER, M. U. G.
HILL, S. C.
JESUS, J. Goes de
AGUIAR, R. S.
IANI, F. C. M.
XAVIER, J.
QUICK, J.
PLESSIS, L. du
DELLICOUR, S.
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
SCIENCE, v.361, n.6405, p.894-899, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The yellow fever virus (YFV) epidemic in Brazil is the largest in decades. The recent discovery of YFV in Brazilian Aedes species mosquitos highlights a need to monitor the risk of reestablishment of urban YFV transmission in the Americas. We use a suite of epidemiological, spatial, and genomic approaches to characterize YFV transmission. We show that the age and sex distribution of human cases is characteristic of sylvatic transmission. Analysis of YFV cases combined with genomes generated locally reveals an early phase of sylvatic YFV transmission and spatial expansion toward previously YFV-free areas, followed by a rise in viral spillover to humans in late 2016. Our results establish a framework for monitoring YFV transmission in real time that will contribute to a global strategy to eliminate future YFV epidemics.
Palavras-chave
Referências
  1. Auguste AJ, 2015, EMERG INFECT DIS, V21, P99, DOI 10.3201/eid2101.140814
  2. Bonaldo MC, 2017, MEM I OSWALDO CRUZ, V112, P447, DOI 10.1590/0074-02760170134
  3. Camara FP, 2011, REV SOC BRAS MED TRO, V44, P297, DOI [10.1590/s0037-86822011005000024, 10.1590/S0037-86822011005000024]
  4. Cardoso JD, 2010, EMERG INFECT DIS, V16, P1918, DOI 10.3201/eid1612.100608
  5. CHANG GJJ, 1995, J VIROL, V69, P5773
  6. Consoli R. A., 1994, PRINCIPAIS MOSQUITOS
  7. Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
  8. do Nascimento Rafaela Almeida, 2013, Neotropical Biology and Conservation, V8, P79, DOI 10.4013/nbc.2013.82.03
  9. Dudas G, 2018, ELIFE, V7, DOI [10.7554/eLife.31257, 10.7554/elife.37324]
  10. Dudas G, 2017, NATURE, V544, P309, DOI 10.1038/nature22040
  11. Estrada A, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1600946
  12. Faria NR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15152-8
  13. Flacio E, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1577-3
  14. Franco O, 1969, HIST FEBRE AMARELA B
  15. Garske T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001638
  16. Gill MS, 2016, SYST BIOL, V65, P1041, DOI 10.1093/sysbio/syw050
  17. Grobbelaar AA, 2016, EMERG INFECT DIS, V22, P1854, DOI 10.3201/eid2210.160818
  18. Jung L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129789
  19. Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI 10.1016/S1473-3099(16)30513-8
  20. Kraemer MU, 2015, ELIFE, V4, DOI 10.7554/ELIFE.08347
  21. Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067
  22. Lourenco-De-Oliveira R, 2004, T ROY SOC TROP MED H, V98, P43, DOI 10.1016/S0035-9203(03)00006-3
  23. Moreira-Soto A, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2018.01.026
  24. Mutebi JP, 2001, J VIROL, V75, P6999, DOI 10.1128/JVI.75.15.6999-7008.2001
  25. NASIDI A, 1989, T ROY SOC TROP MED H, V83, P401, DOI 10.1016/0035-9203(89)90518-X
  26. Nunes MRT, 2012, J VIROL, V86, P13263, DOI 10.1128/JVI.00565-12
  27. PAHO, 2009, OUTBR YELL FEV PAR
  28. Pan American Health Organization/World Health Organization, 2018, EP UPD YELL FEV 16 F
  29. Paules CI, 2017, NEW ENGL J MED, V376, P1397, DOI 10.1056/NEJMp1702172
  30. Pybus OG, 2012, P NATL ACAD SCI USA, V109, P15066, DOI 10.1073/pnas.1206598109
  31. Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
  32. Ribeiro M, 2009, REV SOC BRAS MED TRO, V42, P523, DOI 10.1590/S0037-86822009000500009
  33. Rodrigues Faria Nuno, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.c97507e3e48efb946401755d468c28b2
  34. Secretaria de Vigilancia em Saude Ministerio da Saude, 2015, B EPIDEMIOLOGICO, V46
  35. Secretaria de Vigilancia em Saude Ministerio da Saude, 2017, B EPIDEMIOLOGICO, V48
  36. Segura M. N. O., 2007, ATLAS CULICIDEOS AMA, V167
  37. Shearer FM, 2018, LANCET GLOB HEALTH, V6, pE270, DOI 10.1016/S2214-109X(18)30024-X
  38. Shearer FM, 2017, LANCET INFECT DIS, V17, P1209, DOI 10.1016/S1473-3099(17)30419-X
  39. Stephens Patrick R, 2017, Ecology, V98, P1476, DOI 10.1002/ecy.1799
  40. Theiler M, 1937, J EXP MED, V65, P767, DOI 10.1084/jem.65.6.767
  41. Thiberville SD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002004
  42. Tuboi SH, 2007, T ROY SOC TROP MED H, V101, P169, DOI 10.1016/j.trstmh.2006.04.001
  43. VAINIO J, 1998, YELLOW FEVER
  44. Vasconcelos P F, 2001, Cad Saude Publica, V17 Suppl, P155
  45. Vasconcelos PFC, 2004, EMERG INFECT DIS, V10, P1578, DOI 10.3201/eid1009.040197
  46. Vasconcelos PFC, 2001, J MED VIROL, V65, P598, DOI 10.1002/jmv.2078.abs
  47. Vaughan TG, 2014, BIOINFORMATICS, V30, P2272, DOI 10.1093/bioinformatics/btu201
  48. von Lindern JJ, 2006, J GEN VIROL, V87, P895, DOI 10.1099/vir.0.81536-0
  49. Wang E, 1996, VIROLOGY, V225, P274, DOI 10.1006/viro.1996.0601